Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

APREPITANT vs ARIPIPRAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

APREPITANT vs ARIPIPRAZOLE: Safety Overview

Metric APREPITANT ARIPIPRAZOLE
Total FAERS Reports 5,620 66,335
Deaths Reported 1,195 3,863
Death Rate 21.3% 5.8%
Hospitalizations 2,917 20,713
Average Patient Age 52.8 yrs 39.1 yrs
% Female Patients 70.9% 55.7%
FDA Approval Date Dec 17, 2015 Apr 15, 2025
Manufacturer Heron Therapeutics, Inc. NCS HealthCare of KY, LLC dba Vangard...
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription